Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Abbott’s Navitor TAVR valve linked to positive real-world outcomes
The intra-annular, self-expanding Navitor valve gained FDA approval in 2023 for the treatment of high-risk heart patients with severe aortic stenosis. This analysis explores its early impact on patient care.
Heart teams playing a major role in coronary revascularization decisions
Sunil Rao, MD, discusses the heart team approach in the context of deciding what is best for the patient between bypass surgery and percutaneous coronary intervention.
Heart failure experts share guidance on increasing prevention efforts
Cardiology has been shifting from reactionary treatment strategies to a greater emphasis on prevention. This is an especially important trend in heart failure, which is associated with high costs and rising hospitalization rates.
FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information
The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.
Office-based interventional labs see boost in pay in 2026
CMS has made it a priority to increase payments for procedures performed by office-based labs and ambulatory surgical centers. This was reflected in policy changes made as part of the 2026 Medicare Physicians Fee Schedule.

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

leg veins chronic venous disease PAD peripheral artery disease

Cardiovascular health societies share new performance and quality measures for PAD management

The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.

Newsweek ranked the 50 best heart hospitals in the world

Cardiologists perform first procedure of its kind to prevent coronary obstruction after TAVR

A vulnerable heart patient required TAVR, but he faced an extremely high risk of coronary obstruction. Leaflet modification and snorkel stenting were not possible, so the group turned to a brand new treatment option: the VECTOR procedure.

AI healthcare doctor surgery procedure artificial intelligence

FDA clears next-generation platform for AI-enabled ECG evaluations

AccurECG 2.0 was designed to interpret a total of 13 different rhythm classifications, including atrial fibrillation, atrial flutter and ventricular tachycardia.

New food pyramid cheered and contested, doctors vs. gun harms & other high-level briefings

Keto-diet champions will like the new food pyramid’s emphasis on proteins, including those high in saturated fats. Not everyone shares their predisposition.

FDA: AI-powered medical devices ‘simply providing information’ are not subject to regulation

During a recent segment on Fox Business, Food and Drug Administration Commissioner Martin Makary, MD, clarified new guidance on AI, meant to provide companies with the flexibility to gather and provide data without the agency's approval. However, medical devices that provide "clinical-grade" data will still need to be cleared.

Chest radiograph in a 53-year-old woman with confirmed coronavirus disease 2019, or COVID-19, pneumonia. The patient had fever and cough for 5 days. Multifocal patchy opacities (arrows) can be seen in both lungs. Image courtesy of RSNA. What COVID looks like ob CT medical imaging.

Current imaging AI systems can be repurposed to address future pandemics, study asserts

Experts say these new findings represent “a significant advancement in the field of radiology."

Drugmaker moves ahead with sublingual heart attack treatment after positive FDA meeting

Based on feedback from the FDA, Aspire Biopharma plans on completing a multicenter clinical trial and then seeking regulatory approval for its new high-dose sublingual aspirin therapy.

Clinical

Abbott’s Navitor TAVR valve linked to positive real-world outcomes

Heart teams playing a major role in coronary revascularization decisions

Heart failure experts share guidance on increasing prevention efforts

FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information

Office-based interventional labs see boost in pay in 2026